Browsing by Author "Karuppuchamy, Thangaraj"
Now showing 1 - 2 of 2
Results Per Page
Sort Options
- ItemImplementation of Mass Cytometry as a Tool for Mechanism of Action Studies in Inflammatory Bowel Disease(2018) Tyler, Christopher J.; Perez-Jeldres, Tamara; Ehinger, Erik; Capaldo, Brian; Karuppuchamy, Thangaraj; Boyer, Joshua D.; Patel, Derek; Dulai, Parambir; Boland, Brigid S.; Lannigan, Joanne; Eckmann, Lars; Ernst, Peter B.; Sandborn, William J.; Ho, Samuel B.; Rivera-Nieves, JesusBackground: Novel therapeutics for inflammatory bowel disease (IBD) are under development, yet mechanistic readouts at the tissue level are lacking. Techniques to assess intestinal immune composition could represent a valuable tool for mechanism of action (MOA) studies of novel drugs. Mass cytometry enables analysis of intestinal inflammatory cell infiltrate and corresponding molecular fingerprints with unprecedented resolution. Here, we aimed to optimize the methodology for isolation and cryopreservation of cells from intestinal tissue to allow for the potential implementation of mass cytometry in MOA studies.
- ItemSphingosine-1-Phosphate Lyase Inhibition Alters the S1P Gradient and Ameliorates Crohn's-Like Ileitis by Suppressing Thymocyte Maturation(2020) Karuppuchamy, Thangaraj; Tyler, Christopher J.; Lundborg, Luke R.; Perez-Jeldres, Tamara; Kimball, Abigail K.; Clambey, Eric T.; Jedlicka, Paul; Rivera-Nieves, JesusBackground: Lymphocytes recirculate from tissues to blood following the sphingosine-1-phosphate (S1P) gradient (low in tissues, high in blood), maintained by synthetic and degradative enzymes, among which the S1P lyase (SPL) irreversibly degrades S1P. The role of SPL in the intestine, both during homeostasis and IBD, is poorly understood. We hypothesized that modulation of tissue S1P levels might be advantageous over S1P receptor (S1PR) agonists (eg, fingolimod, ozanimod, etrasimod), as without S1PR engagement there might be less likelihood of potential off-target effects.